{"id":942700,"date":"2026-03-06T16:04:15","date_gmt":"2026-03-06T21:04:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/"},"modified":"2026-03-06T16:04:15","modified_gmt":"2026-03-06T21:04:15","slug":"mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/","title":{"rendered":"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, March  06, 2026  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0<strong>Mereo BioPharma Group plc (NASDAQ: MREO).<\/strong><\/p>\n<p>Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OePRM79ooK8oAIA63GcO59VDPdLf7J_NXUUui5PU0CumkBZqdOGEaTWavIpch6cUSQgOYEWF2nKMev8_woRSwkSZx6U90W2q4ISA600YtPaNZDALt6Ns0Z7ykfN9kmYFcXaIxFXD0lY3itCk63LLDF12VAEMgZ4c0Mg6fnXXgZJSRKLzdJIf9IahGWSUAoulQgq2bj7Ktc-O5rgES04gGVaziH7llof_qP5ZsG-b0KBWRrHFta9fcCl24ts5KWju19r--YdtN6a3ii2vn-fwnDUNVs06UUIVD2iuE7eO_fDzhmVOhUOEOoYxzpmAbHWj_dLxfFDYAC3XVtHXgokJOQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/mereo-biopharma-group-plc-loss-submission-form-5\/?id=184108&amp;from=3<\/a>\n      <\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>June 5, 2023 to December 26, 2025<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of the Phase 3 ORBIT and COSMIC programs; neither of which hit its primary endpoints of reducing annualized clinical fracture rate compared to the placebo or bisphosphonate control groups, respectively. On December 29, 2025, Mereo issued a press release announcing that neither the ORBIT nor the COSMIC Phase 3 studies achieved statistical significance. The press release indicated that neither study met its primary endpoint of reduction in annualized clinical fracture rate compared to placebo or bisphosphonates, respectively, despite improved bone mineral density. Following this news, the price of Mereo\u2019s ADS declined dramatically. From a closing market price of $2.31 per share on December 26, 2025, Mereo\u2019s ADS price fell to $0.29 per share on December 29, 2025, a decline of more than 87.7%.<\/p>\n<p>\n        <strong>DEADLINE: April 6, 2026<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OePRM79ooK8oAIA63GcO59VDPdLf7J_NXUUui5PU0CumkBZqdOGEaTWavIpch6cUSQgOYEWF2nKMev8_woRSwkSZx6U90W2q4ISA600YtPaNZDALt6Ns0Z7ykfN9kmYFcXaIxFXD0lY3itCk63LLDHVKqJ_RHWdOCwIpSucxNjEwIEF6DBPzQgpDjjfH7iRf36qV-6dT4HtGx7YZ-v7UrBw1KGyg95VEBlKxXJzVz5t5Y5PSI4njGuEOoRckm1YpvJMbUhJJnGvz8pvn-C3XQnBKsDBMyaTrRHsjOLdGC6KpMaDZgECee7nd7Pz2MUbQupShTR3INMUFWh1lo4SLmw==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/mereo-biopharma-group-plc-loss-submission-form-5\/?id=184108&amp;from=3<\/a><\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of MREO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 6, 2026. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tXzPv_iPmUGDXVxIlOxh_nI8TkVSfI-jNgMYmV19XcbUnfuqa2xZ4XmG8IwWNHLgxAX6XqUG-xe_sRZSOFDlD6yX5ISOsSA8xUC-f-t3xsaIHV0wjFz1fUNeaQzporxt\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDA3MTMwNzEtZDBiOS00ZGVjLTk1NjEtYmU2MThiMTE1MmU0LTEyNzA0NjctMjAyNi0wMy0wNi1lbg==\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Mereo BioPharma Group plc (NASDAQ: MREO). Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/mereo-biopharma-group-plc-loss-submission-form-5\/?id=184108&amp;from=3 CLASS PERIOD: June 5, 2023 to December 26, 2025 ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of the Phase 3 ORBIT and COSMIC programs; neither of which hit its primary endpoints of reducing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-942700","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Mereo BioPharma Group plc (NASDAQ: MREO). Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/mereo-biopharma-group-plc-loss-submission-form-5\/?id=184108&amp;from=3 CLASS PERIOD: June 5, 2023 to December 26, 2025 ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of the Phase 3 ORBIT and COSMIC programs; neither of which hit its primary endpoints of reducing &hellip; Continue reading &quot;Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-06T21:04:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO\",\"datePublished\":\"2026-03-06T21:04:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/\"},\"wordCount\":458,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/\",\"name\":\"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=\",\"datePublished\":\"2026-03-06T21:04:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/","og_locale":"en_US","og_type":"article","og_title":"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO - Market Newsdesk","og_description":"NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Mereo BioPharma Group plc (NASDAQ: MREO). Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/mereo-biopharma-group-plc-loss-submission-form-5\/?id=184108&amp;from=3 CLASS PERIOD: June 5, 2023 to December 26, 2025 ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of the Phase 3 ORBIT and COSMIC programs; neither of which hit its primary endpoints of reducing &hellip; Continue reading \"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-06T21:04:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO","datePublished":"2026-03-06T21:04:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/"},"wordCount":458,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/","name":"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=","datePublished":"2026-03-06T21:04:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyNiM3NDcwNDM5IzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mereo-biopharma-group-plc-class-action-the-gross-law-firm-reminds-mereo-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026-mreo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 \u2013 MREO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=942700"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942700\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=942700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=942700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=942700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}